Literature DB >> 9712420

p53 alterations in atypical alveolar hyperplasia of the human lung.

R J Slebos1, I O Baas, M J Clement, G J Offerhaus, F B Askin, R H Hruban, W H Westra.   

Abstract

Atypical alveolar hyperplasia (AAH) is a potential precursor lesion from which lung adenocarcinomas arise and may be a good target for studying the early events of lung tumorigenesis. We have previously shown that AAHs are neoplastic epithelial proliferations that often harbor activating mutations of the K-ras oncogene. In the current study, we examined a spectrum of AAHs to determine the frequency and timing of p53 alterations in lung tumorigenesis. We analyzed 37 AAHs and their paired overt lung neoplasms for p53 protein accumulation using the monoclonal antibody DO7. DNA sequence analysis of the p53 gene was performed on those cases demonstrating p53 protein accumulation. AAHs were classified as low-grade, high-grade, or AAH-like carcinoma based on cytoarchitectural features. Accumulation of the p53 protein was found in none (0%) of 20 low-grade AAHs, in 1 (9%) of 11 high-grade AAHs, and in three (50%) of six AAH-like carcinomas. There was a statistically significant trend toward p53 accumulation with increasing grade of the AAHs. A missense mutation in exon 7 of the p53 gene was found in 1 AAH-like carcinoma, whereas mutations in exons 5 through 8 could not be detected in the other three AAHs with p53 protein accumulation. Three of the paired overt carcinomas harbored p53 mutations that were not present in the AAHs. Alterations of p53 do not appear to be common events in AAHs, especially when these lesions exhibit low-grade cytoarchitectural features. Alterations of p53, however, are more frequent at the level of AAH-like carcinoma and may be associated with the transition from a benign to a malignant proliferation of pneumocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712420     DOI: 10.1016/s0046-8177(98)90448-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

Review 1.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

2.  Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia.

Authors:  R Nakahara; T Yokose; K Nagai; Y Nishiwaki; A Ochiai
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 3.  Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.

Authors:  Jody C Chuang; Joseph B Shrager; Heather A Wakelee; Joel W Neal
Journal:  Clin Ther       Date:  2016-06-29       Impact factor: 3.393

4.  Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

Authors:  Julien D F Licchesi; William H Westra; Craig M Hooker; Emi O Machida; Stephen B Baylin; James G Herman
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

5.  Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.

Authors:  Xin-Zi Chi; Jiyeon Kim; Yong-Hee Lee; Jung-Won Lee; Kyeong-Sook Lee; Heejun Wee; Wun-Jae Kim; Woo-Yoon Park; Byung-Chul Oh; Gary S Stein; Yoshiaki Ito; Andre J van Wijnen; Suk-Chul Bae
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

Review 6.  Preneoplastic lesions of the lung.

Authors:  Alissa K Greenberg; Herman Yee; William N Rom
Journal:  Respir Res       Date:  2002-04-04

Review 7.  Early glandular neoplasia of the lung.

Authors:  W H Westra
Journal:  Respir Res       Date:  2000-11-17

8.  Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.

Authors:  Evgeny Izumchenko; Xiaofei Chang; Mariana Brait; Elana Fertig; Luciane T Kagohara; Atul Bedi; Luigi Marchionni; Nishant Agrawal; Rajani Ravi; Sian Jones; Mohammad O Hoque; William H Westra; David Sidransky
Journal:  Nat Commun       Date:  2015-09-16       Impact factor: 14.919

9.  Chronic lung injury by constitutive expression of activation-induced cytidine deaminase leads to focal mucous cell metaplasia and cancer.

Authors:  Jiro Kitamura; Munehiro Uemura; Mafumi Kurozumi; Makoto Sonobe; Toshiaki Manabe; Hiroshi Hiai; Hiroshi Date; Kazuo Kinoshita
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers.

Authors:  Mandar Deepak Muzumdar; Kimberly Judith Dorans; Katherine Minjee Chung; Rebecca Robbins; Tuomas Tammela; Vasilena Gocheva; Carman Man-Chung Li; Tyler Jacks
Journal:  Nat Commun       Date:  2016-09-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.